Table 6.
Current employment situation for patients with severe anxiety in both groups.
| Characteristics | With Revasc. (n = 12) | Without Revasc. (n = 32) | ||||
|---|---|---|---|---|---|---|
| With Income (n = 10) |
Without Income (n = 2) |
p Value | With Income (n = 26) |
Without Income (n = 6) |
p Value | |
| Total pts | 10 (85%) | 2 (15%) | 0.028 sa | 26 (81.8%) | 6 (18.2%) | 0.033 sa |
| Female sex | 7(87.5%) | 1 (12.5%) | 0.019 sa | 15 (83.3%) | 3 (16.6%) | 0.030 sa |
| HAD-A | 15.7 ± 1.16 | 16.8 ± 0.98 | 0.209 b | 15.5 ± 0.52 | 17.8 ± 1.68 | <0.001 sb |
| HAD-D | 9.7 ± 1.16 | 9.6 ± 3.21 | 0.928 b | 10.2 ± 2.54 | 11.2 ± 2.59 | 0.383 b |
| DUKE | 22.2 ± 2.84 | 19.9 ± 11.68 | 0.482 b | 27.1 ± 12.79 | 23.3 ± 10.57 | 0.520 b |
| DS-14 IS | 9.3 ± 4.62 | 14.3 ± 9.01 | 0.373 b | 8.6 ± 8.46 | 12.8 ± 9.76 | 0.209 b |
| DS-14 AN | 23.0 ± 6.25 | 22.2 ± 6.98 | 0.864 b | 24.9 ± 3.71 | 25.9 ± 4.49 | 0.343 b |
a—Chi2 Test; b—Mann-Whitney U Test; s—signification.